Reuters: Regulatory News: Third Wockhardt India plant hit by export restrictions

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

The Best Way to Manage your Money. Start using Mint today to set a budget, track your goals and do more with your money. From our sponsors

Third Wockhardt India plant hit by export restrictions Oct 22nd 2013, 07:05 Share this Email Print Reprints Tue Oct 22, 2013 3:05am EDT Oct 22 (Reuters) - Britain's drug regulator revoked the quality compliance certificate for a Wockhardt Ltd factory in India, the drugmaker said on Tuesday, the third of its plants to be hit by export restrictions this year. The UK Medicines and Healthcare Products Regulatory Agency will instead issue a restricted certificate, which means Wockhardt will be able to supply only "critical" products from the factory located in Kadaiya in western India, the company said in a statement. Earlier this month, the UK regulator took away the generic drugmaker's good manufacturing practice (GMP) certificate for its key Chikalthana factory. Last week, the UK regulator issued a recall for drugs made at the plant. The UK regulator's measures followed a ban by the U.S. Food and Drug Administration on drug shipments to the United States from a separate Wockhardt factory in Waluj, after hygiene and other compliance deficiencies were found. The UK agency later recalled products made at the Waluj plant. Wockhardt, which has seven plants in India, said on Tuesday the impact of the MHRA's decision on existing business will only be known once it receives further communication. The company's shares were down as much as 4 percent after it issued the statement before paring some losses to trade down 2 percent at 468.35 rupees. The main index was trading down 0.2 percent. Its shares have lost nearly 80 percent since their record-high in March. Link this Share this Digg this Email Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions